内蒙古中医药
內矇古中醫藥
내몽고중의약
INNER MONGOL JOURNAL OF TRADITIONAL CHINESE MEDICINE
2015年
4期
63-64
,共2页
博尔宁胶囊%化疗%胃癌%中医药%肿瘤
博爾寧膠囊%化療%胃癌%中醫藥%腫瘤
박이저효낭%화료%위암%중의약%종류
Boerning capsules%Chemotherapy%Gastric cancer%Traditional Chinese medicine%cancer
目的：：明确博尔宁胶囊联合替吉奥治疗晚期胃癌患者的疗效、生活质量及毒副作用。方法：将60例晚期胃癌患者随机分为两组：实验组30例（博尔宁胶囊联合替吉奥治疗组）；对照组30例（替吉奥单药治疗组）。比较二组患者的治疗效果、生活治疗及毒副反应。结果：实验组治疗有效率为56.67%，对照组治疗有效率为36.67%。实验组患者经治疗后毒副反应发生率低（P<0.05），且生活质量高于对照组（P<0.05）。结论：博尔宁胶囊联合替吉奥治疗晚期胃癌患者可提高治疗效果，降低化疗毒副反应的发生率，提高患者生活质量。
目的：：明確博爾寧膠囊聯閤替吉奧治療晚期胃癌患者的療效、生活質量及毒副作用。方法：將60例晚期胃癌患者隨機分為兩組：實驗組30例（博爾寧膠囊聯閤替吉奧治療組）；對照組30例（替吉奧單藥治療組）。比較二組患者的治療效果、生活治療及毒副反應。結果：實驗組治療有效率為56.67%，對照組治療有效率為36.67%。實驗組患者經治療後毒副反應髮生率低（P<0.05），且生活質量高于對照組（P<0.05）。結論：博爾寧膠囊聯閤替吉奧治療晚期胃癌患者可提高治療效果，降低化療毒副反應的髮生率，提高患者生活質量。
목적：：명학박이저효낭연합체길오치료만기위암환자적료효、생활질량급독부작용。방법：장60례만기위암환자수궤분위량조：실험조30례（박이저효낭연합체길오치료조）；대조조30례（체길오단약치료조）。비교이조환자적치료효과、생활치료급독부반응。결과：실험조치료유효솔위56.67%，대조조치료유효솔위36.67%。실험조환자경치료후독부반응발생솔저（P<0.05），차생활질량고우대조조（P<0.05）。결론：박이저효낭연합체길오치료만기위암환자가제고치료효과，강저화료독부반응적발생솔，제고환자생활질량。
Objective:To evaluate the efficacy, toxicity and adverse reactions of S-1 alone or in combination with Boerning capsules for advanced gastric cancer.Methods:Sixty patients with advanced gastric cancer were randomly divided into two groups: trial group (n=30) received Boerning capsules and S-1, and control group (n=30) only accepted chemotherapy. The response rate, toxicity and quality of life (QQL) were compared in two groups. Results:There were differences between the trial group and the control group in response rate ( 56.67%and 36.67%,P<0.05),and the trial group had milder adverse reactions yet better improvement of symptoms than in the control group(P<0.05) . Conclusion:Addition of Boerning capsules to S-1 resulted in better efficacy yet milder adverse reactions of chemotherapy and better quality of life in patients with advanced gastric cancer.
